MARIA ESTRADA: Open Payments
NPI 1821311697 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 9 payments from 7 companies in 2025. Trend: 2023 $430 · 2024 $314 · 2025 $598
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $241 |
| Penumbra, Inc. | 1 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| ABBVIE INC. | 2 | $39 |
| Boston Scientific Corporation | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: NUCALA, Indigo System, AIRSUPRA, QULIPTA, RESONATE EL ICD VR, ELIQUIS, RYBREVANT.
Industry payments across FL — which companies pay providers there.
